Transcat, Inc. (NASDAQ:TRNS) Shares Purchased by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD boosted its holdings in Transcat, Inc. (NASDAQ:TRNS) by 18.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,567 shares of the scientific and technical instruments company’s stock after acquiring an additional 559 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Transcat were worth $378,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp grew its stake in Transcat by 686.7% in the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock valued at $37,000 after acquiring an additional 309 shares during the last quarter. Morgan Dempsey Capital Management LLC acquired a new stake in Transcat in the 4th quarter valued at about $143,000. SG Americas Securities LLC acquired a new stake in Transcat in the 4th quarter valued at about $182,000. KLP Kapitalforvaltning AS acquired a new stake in Transcat in the 4th quarter valued at about $190,000. Finally, XTX Topco Ltd acquired a new stake in Transcat in the 4th quarter valued at about $326,000. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Trading Down 2.6%

NASDAQ TRNS opened at $79.29 on Thursday. Transcat, Inc. has a one year low of $67.56 and a one year high of $147.12. The company’s 50 day moving average price is $77.27 and its 200 day moving average price is $90.40. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The firm has a market capitalization of $738.11 million, a price-to-earnings ratio of 42.86 and a beta of 0.69.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Oppenheimer cut shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, February 5th. Northland Securities reaffirmed a “market perform” rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Finally, HC Wainwright decreased their price target on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $111.50.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.